CNMP Exam Domains 2026: Complete Guide to All 3 Content Areas

The Blueprint: Three Categories, One Outline

Clinical Neuromuscular Pathology certification is issued by the United Council for Neurologic Subspecialties (UCNS), and the exam is built from a single published document: the Clinical Neuromuscular Pathology Certification Examination Content Outline. That outline divides everything you can be tested on into three primary categories, each broken into lettered sections and numbered objectives. If you read nothing else before you start studying, read that outline. It is the most direct statement of what the exam covers.

One caution about sourcing. The public outline carries no verified edition date, and its footer shows a revision stamp of 10-09-18. UCNS also changes logistics from cycle to cycle. Treat the outline as your content map, and treat the UCNS certification page as the authority for scheduling and delivery. For a broader orientation to the credential itself, see What Is CNMP Certification? and the eligibility rules in CNMP Requirements 2026: Eligibility, Prerequisites & How to Qualify.

How the Weights Shape Your Study Time

The weights are lopsided in a useful way. Domains 2 and 3 each carry 40%, which means a candidate who has mastered both muscle and nerve morphology has secured 80% of the exam's territory. Domain 1 is smaller, but it is not a throwaway. It contains the foundations (site selection, specimen handling, anatomy, electrophysiology) that make the disease-specific questions easier to reason through.

With 200 questions on the exam, the stated weights imply roughly 40 questions from Domain 1 and roughly 80 each from Domains 2 and 3. Treat those counts as approximations derived from the percentages rather than a published guarantee. The practical point is that a weak spot in Domain 2 or 3 costs far more than a weak spot in Domain 1, and it is harder to recover from.

Domain 1: Core Clinical Neuromuscular Pathology (20%)

The first category covers the practical side of getting tissue and understanding what you are looking at. It has four lettered sections: performance and processing of biopsies, complications of biopsies, nerve and muscle anatomy, and nerve and muscle electrophysiology.

Performance and Processing of Biopsies

This section tests site selection and specimen type and purpose. The recurring skill is matching the question being asked clinically to the right tissue, the right site, and the right handling. A biopsy that is technically perfect but taken from an end-stage muscle tells you very little, and the exam expects you to recognize that.

Complications of Biopsies

Here the outline separates the choice of site for muscle biopsies, artifacts due to the muscle biopsy procedure, the choice of site for nerve biopsies, and artifacts due to the nerve biopsy procedure. The framing matters: these are not just surgical complications, they are the ways the procedure itself can create findings that mimic disease. This theme returns in Domains 2 and 3, so build the habit early of asking whether a feature is pathology or procedure.

Anatomy and Electrophysiology

The last two sections are broad by design. Nerve and muscle anatomy supports everything from fiber-type interpretation to recognizing nerve compartments, and nerve and muscle electrophysiology gives you the clinical correlation needed to interpret biopsy findings. Expect to connect an electrophysiologic pattern with the histology you would predict.

Domain 2: Muscle Diseases (40%)

This is the largest and most densely structured category, with twelve lettered sections (A through L). It rewards candidates who think in a sequence: first rule out artifact, then establish what is normal, then identify the basic reaction patterns, and only then name the disease.

Artifacts and What Is Normal (Sections A and B)

The outline lists freezing artifacts, sectioning artifacts, staining artifacts, insufficient biopsy size, and common mitochondrial artifacts (swelling, size variation, cristae, inclusions). Normal variation includes age-related features such as fiber size in development, ragged red fibers in aging, lipofuscin, and the amount and size of lipid droplets. These two sections exist to stop you from over-calling disease. A ragged red fiber in an elderly patient is not automatically a mitochondrial myopathy, and the exam knows it.

Basic Reactions of Muscle (Section C)

Section C is the analytic core, with seventeen numbered objectives. It covers fiber type patterns and histochemical properties, analysis of fiber diameters, central migration of nuclei, necrotic and regenerating fibers (including plump basophilic nuclei and "split" fibers from incomplete fusion), connective tissue evaluation, and fiber inclusions. It also separates type 2 fiber atrophy from type 1 fiber atrophy, and covers denervation, reinnervation, and chronic denervation with reinnervation. Then come the named structural findings: target fibers, moth-eaten fibers, myofibrillar myopathies (desmin and others), inclusion bodies, cytoplasmic bodies, and autophagolysosomes with lysosomal accumulation.

Congenital, Metabolic, and Channel Disorders (Sections D, E, F)

For congenital myopathies, the outline asks for specific morphologic features, nonspecific morphologic features, and currently recognized disease genes. The metabolic section covers glycogen storage myopathies (features, histochemical methods, etiologies), lipid storage myopathy (including normal lipid droplet size and density), histologic features pointing to mitochondrial myopathies, mitochondrial abnormalities secondary to aging, and the time course of regeneration and resolution of necrosis after rhabdomyolysis. Channelopathies are narrower: the histologic features associated with sodium and potassium channelopathies of skeletal muscle.

Inflammatory, Systemic, and Dystrophic Disease (Sections G, H, I)

The inflammatory section centers on the concept of primary inflammation surrounding and invading non-necrotic myofibers, plus methods to phenotype inflammatory cells, display the fiber microvasculature, and distinguish necrotizing vasculitis from other types. It also includes identification of parasites in muscle and pyomyositis. Systemic disorders include systemic sclerosis, sarcoidosis, amyloid deposits and their causes, hypokalemic myopathy, uremic hyperparathyroidism, malnutrition, and critical illness myopathy.

The muscular dystrophy section is distinctive because it blends histology with molecular testing. You need the gene-centered classification, general dystrophic histology, the available monoclonal antibody tests, the special features suggesting dystrophinopathy, sarcoglycanopathy, dysferlinopathy, and myofibrillar myopathy, and the available gene tests for specific diagnosis.

Neurogenic, Toxic, and Junction Disorders (Sections J, K, L)

Neurogenic disease asks for patterns of recent denervation and patterns of chronic denervation with reinnervation. The toxic and mechanical section is a list worth memorizing by name: statin myopathy and other necrotizing myopathies, emetine, colchicine, chloroquine, zidovudine, HMG-CoA reductase inhibitors, fibric acid derivatives, organophosphate poisoning, acute alcoholic myopathy (differentiating necrotizing from vacuolar), myopathy from intramuscular injections, and focal myopathy caused by EMG examination. Finally, the neuromuscular junction section covers identification in biopsies by the nonspecific esterase reaction and detection of immune deposits (C3, C5b9, and Protein A reactivity).

For a compact review aid covering this material, the CNMP Cheat Sheet 2026: One-Page Review of Must-Know Facts is a useful companion.

Domain 3: Nerve Diseases (40%)

The nerve category has nine lettered sections (A through I). Its first section is the structural foundation, and the rest are organized by disease etiology.

Basic Histological Alterations and Artifacts (Section A)

This section is where nerve pathology is taught as a language. Under nerve fiber alterations, you need to identify the tissue type (peripheral nerve, ventral and dorsal root, spinal and autonomic ganglia, and nerve endings in skin), grade fiber number as normal, decreased, or increased, and describe the size distribution of fibers, including selective loss of large myelinated, small myelinated, or unmyelinated fibers.

The outline then walks through teased fiber pathology using a lettered scheme: normal (A), myelin wrinkling (B), segmental demyelination (C), demyelination and remyelination (D), axonal degeneration (E), remyelination (F), myelin reduplication (G), and axonal regeneration after degeneration (H), plus distal axonal degeneration. Axon alterations include enlargement, atrophy, dark axons with light cores suggestive of ischemic injury, spheroids, polyglucosan bodies, glycogen accumulation, and adaxonal sequestration. Myelin and Schwann cell alterations include irregularity, onion bulbs, reduplication, increased lamellar spacing, and Schwann cell inclusions (MLD, Krabbe, Fabry).

The interstitial compartments are tested separately: endoneurium (size, fluid, connective tissue, inflammatory and neoplastic cells, vessels, CD45 and CD68 infiltrates, hemosiderin), perineurium (lamella number, focal or generalized increase, infiltration), and epineurium (vessel degeneration such as atherosclerosis and medial calcification, basement membrane reduplication, amyloid, granuloma). Nerve artifacts include crush, freezing, poor fixation, poor osmication from inadequate infiltration, and inadequate controls.

Hereditary, Metabolic, and Immune Neuropathies (Sections B, C, D)

Hereditary and congenital (non-metabolic) disease covers aplasia of normal nerve fiber populations, maldevelopment of fiber classes (HSAN 2 through 5), inclusions in errors of metabolism (MLD, Krabbe, Tay-Sachs, ALD, Fabry, Tangier disease), giant axonal polyneuropathy, and neuroaxonal dystrophy.

The metabolic section spans diabetic neuropathies (cranial, typical distal symmetric, atypical, radiculoplexus forms, and compression and entrapment neuropathies), acromegaly, hypothyroid, hepatic and xanthomatous neuropathy, MEN 2b, nutritional deficiency neuropathies (after bariatric surgery, from deficiencies generally, and copper deficiency), and porphyria.

The inflammatory and immune section is high-yield. It separates acute inflammatory demyelinating forms (AIDP, AMAN) from chronic forms (CIDP, multifocal CIDP or MADSAM, sensory CIDP, CISP, and MGUS-associated neuropathy). It also covers multifocal motor neuropathy with conduction block, large vessel nerve vasculitis, nerve microvasculitis (DLRPN, LRPN, inflammatory brachial plexopathy), and sarcoid neuropathy.

Infectious, Ischemic, Tumor, Toxic, and Miscellaneous (Sections E through I)

Infectious neuropathies include syphilis, HIV, leprosy (lepromatous, tuberculoid, and mixed), Lyme borreliosis, Chagas disease, herpes simplex, and herpes zoster. Ischemic neuropathies cover diabetes-associated ischemia, necrotizing vasculitis of nerve large arterioles and microvessels, and atherosclerosis. The tumor section includes sheath tumors (schwannoma, neurofibroma), perineurioma, secondary tumors, lymphoma-associated and paraneoplastic neuropathy, amyloid neuropathy (inherited and monoclonal-associated), and POEMS syndrome.

Toxic neuropathy covers industrial agents, metal neuropathies (arsenic, mercury, thallium, gold, platinum), and drug-related neuropathies. The miscellaneous section closes with autonomic neuropathies and entrapment neuropathies.

Exam Format and Logistics

According to the UCNS certification page, the Clinical Neuromuscular Pathology examination is offered biennially in odd-numbered years, is scheduled for five hours, and contains 200 multiple-choice questions. Effective January 1, 2025, it is administered either at testing centers or online with virtual live proctoring. That averages out to a pace of roughly 90 seconds per question across the full session, which leaves little room for lingering on any single item. Because the exam is only offered every other year, a missed or failed attempt carries a long wait, which raises the stakes of a well-planned first attempt.

Fees, passing score, and pass rate are not covered here because they are not part of the verified public outline details used for this article. Check the UCNS site directly, and see CNMP Exam Dates 2026: Testing Windows, Deadlines & Scheduling, CNMP Certification Cost 2026: Complete Pricing Breakdown, and CNMP Passing Score 2026: Exactly What You Need to Pass for the logistics side.

Sequencing the Three Domains

Generic scheduling advice is less useful here than a sequence that follows the way the outline builds on itself. One workable order, adjustable to your own timeline:

The logic is that Domain 1 and the artifact sections are prerequisites for interpreting everything else, and the basic reactions (muscle) and basic histological alterations (nerve) are prerequisites for the disease sections. For a fuller plan, see the CNMP Study Guide 2026: How to Pass on Your First Attempt, and use the CNMP practice tests to find out which domain needs the most work before you commit to a schedule.

Where Candidates Lose Points

Based on how the outline is structured, a few failure patterns are predictable:

• Calling artifact as disease. Freezing, sectioning, staining, crush, and fixation artifacts are all explicitly tested. Candidates who go straight to a diagnosis without ruling these out get caught.
• Treating the toxic list as an afterthought. The toxic and mechanical muscle section names specific agents, and the nerve toxic section names specific metals. These are fact-recall items that reward direct memorization.
• Neglecting the molecular layer. The dystrophy and congenital myopathy sections explicitly include genes, monoclonal antibody tests, and gene tests. Morphology alone is not enough.
• Underweighting nerve teased-fiber pathology. The lettered teased-fiber scheme is easy to skim and hard to apply under time pressure.
• Studying from the wrong credential's materials. Because several unrelated certifications share the same acronym, make sure every resource you use maps to this specific outline.

If you are weighing whether the effort is justified, Is the CNMP Certification Worth It? Complete ROI Analysis 2026 and the CNMP Jobs overview address the career side.

Frequently Asked Questions